WILLF (Demant AS) ROCE %: 12.08% (As of Dec. 2025)


WILLF Demant AS WILLF
90 GF Score
Price $39.12
GF Value $49.15
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Demant AS ROCE %?

Demant AS WILLF 90 ROCE % is 12.08% as of Dec. 2025. GuruFocus rates WILLF with a GF Score™ of 90/100 and a GF Value™ of $49.15 (Modestly Undervalued). The stock has 5 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Demant AS's annualized ROCE % for the quarter that ended in Dec. 2025 was 12.08%.

Demant AS  (OTCPK:WILLF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Demant AS ROCE % Related Terms

Demant AS ROCE % Historical Data

* Premium members only.

The historical data trend for Demant AS's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Demant AS ROCE % Chart

Demant AS Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.16 18.84 20.62 17.12 13.23

Demant AS Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.75 18.36 16.35 14.96 12.08
WILLF
90GF Score
Demant AS WILLF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Demant AS ROCE % Calculation

Demant AS's annualized ROCE % for the fiscal year that ended in Dec. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Dec. 2025 )  (A: Dec. 2024 )(A: Dec. 2025 )
=572.871/( ( (4556.24 - 855.787) + (6125.988 - 1163.771) )/ 2 )
=572.871/( (3700.453+4962.217)/ 2 )
=572.871/4331.335
=13.23 %

Demant AS's ROCE % of for the quarter that ended in Dec. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Dec. 2025 )  (Q: Jun. 2025 )(Q: Dec. 2025 )
=550.294/( ( (5046.382 - 895.795) + (6125.988 - 1163.771) )/ 2 )
=550.294/( ( 4150.587 + 4962.217 )/ 2 )
=550.294/4556.402
=12.08 %

(1) Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 12.08% mean?
Demant AS (WILLF) has a ROCE % of 12.08% as of Dec. 2025.
Is Demant AS's ROCE % too high?
Demant AS's current ROCE % is 12.08%. The Medical Devices & Instruments industry median ROCE % is 2.23. Demant AS's value of 12.08% is 441.7% above this industry median. Overall, Demant AS has a GF Score™ of 90/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Demant AS's ROCE % compare to ABT and SYK?
Demant AS's ROCE % of 12.08% can be compared against companies in the Medical Devices & Instruments industry. The industry median ROCE % is 2.23. Demant AS's value of 12.08% is 441.7% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Medical Devices & Instruments company?
The median ROCE % among Medical Devices & Instruments companies is 2.23, based on 814 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Demant AS's current ROCE % of 12.08% is 441.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Medical Devices & Instruments industry, the median ROCE % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Demant AS's current ROCE % is 12.08%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Demant AS stock overvalued right now?
Based on GuruFocus' analysis, Demant AS (WILLF) is currently considered Modestly Undervalued. The stock's GF Value™ is $49.15, compared to a current price of $39.12 — trading 20.4% below its estimated fair value. The current ROCE % is 12.08% and 441.7% above the Medical Devices & Instruments industry median of 2.23. Demant AS's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Demant AS (WILLF), the current ROCE % is 12.08% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Demant AS (WILLF) Overvalued in 2026?

Based on GuruFocus' analysis, Demant AS stock appears to be undervalued. The current stock price of $39.12 is trading 20.4% below its estimated GF Value™ of $49.15. GuruFocus considers Demant AS to be Modestly Undervalued.

Key valuation signals for WILLF:

  • ROCE %: 12.08%
  • GF Value™: $49.15 vs. price of $39.12 (20.4% below fair value)
  • GF Score™: 90/100 with 5 warning signs
  • Industry Position: 441.7% above the Medical Devices & Instruments median

No single metric tells the full story. See the WILLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Demant AS Business Description

Address Kongebakken 9, Smorum, DNK, 2765
Demant is a Denmark-based manufacturer and distributor of hearing solutions, such as hearing aid devices and diagnostic equipment. More than 80% of the company's sales come from North America and Europe.
90GF Score

Get the complete analysis for WILLF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$39.12
Price
$49.15
GF Value